(Nasdaq: PSNL), a leader in advanced genomics for precision oncology, today announced that it has achieved UKCA (United Kingdom Conformity Assessed) marking for its NeXT Personal Dx test. This ...
Regulatory milestone for the NeXT Personal Dx test enables clinical use of Personalis' ultrasensitive MRD detection in Great BritainPersonalis, Inc. (Nasdaq: PSNL), a leader in advanced genomics for p ...
An adolescent boy presented with vague respiratory symptoms and mild right upper quadrant abdominal pain. Following physical ...
Morning Overview on MSN
A prostate cancer drug halved the odds of the disease spreading
Men diagnosed with high-risk localized prostate cancer now have trial-level evidence that adding the drug apalutamide to ...
Drs Ursula A. Matulonis and Marisa R. Nucci discuss the future of AI and pathology and how genetics and genomics play a role ...
Optiscan expects the US FDA to clear its Inspecta veterinary imaging device – without the agency saying a word.
A woman in her early 20s underwent bilateral photorefractive keratectomy (PRK) for correction of myopia. She developed ...
The Cystic Fibrosis Foundation organised a multidisciplinary committee to develop this Position Paper to outline current ...
Asthma is the most common chronic airway disease worldwide, imposing substantial clinical, societal, and economic burden.
Some results have been hidden because they may be inaccessible to you
Show inaccessible results